• 图片1

N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide

  • CasNo:871700-17-3

Product Description

Reputable factory supply N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide 871700-17-3 in bulk at low price

  • Molecular Formula: C26H23FIN5O4
  • Molecular Weight: 615.403
  • Melting Point: 300-301 °C 
  • PKA: 14.76±0.70(Predicted) 
  • PSA: 110.62000 
  • Density: 1.743 g/cm3 
  • LogP: 4.66260 

871700-17-3 Relevant articles

Method for synthesizing key intermediate of trametinib

-

Paragraph 0029, (2019/02/27)

The invention discloses a method for syn...

Method for synthesizing trametinib

-

Paragraph 0033; 0034; 0037; 0041; 0045, (2019/02/25)

The invention discloses a method for syn...

SOLVATE FORM M OF TRAMETINIB DIMETHYL SULFOXIDE AND METHODS OF MAKING AND USING THEREOF

-

Paragraph 0093, (2015/06/10)

The present invention relates to a cryst...

5-AMINO-2,4,7-TRIOXO-3,4,7,8-TETRAHYDRO-2H-PYRIDO’2,3-D! PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CANCER

-

Page/Page column 149, (2008/06/13)

The present invention relates to a pyrim...

871700-17-3 Process route

N-{3-[3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide
871700-25-3

N-{3-[3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide

trametinib
871700-17-3

trametinib

Conditions
Conditions Yield
N-{3-[3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide; With sodium methylate; In tetrahydrofuran; methanol; at 20 ℃; for 4h;
With acetic acid; In tetrahydrofuran; methanol; at 20 ℃; for 0.5h;
95%
With sodium methylate;
95%
N-{3-[3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide; With sodium methylate; In tetrahydrofuran; methanol; at 20 ℃; for 4h;
With acetic acid; In tetrahydrofuran; methanol; at 20 ℃; for 0.5h; Product distribution / selectivity;
With sodium methylate; In tetrahydrofuran; methanol; at 20 ℃; for 4h; Inert atmosphere;
4.75 g
1-(3-aminophenyl)-3-cyclopropyl-5-{(2-fluoro-4-iodophenyl)amino}-6,8-dimethylpyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione

1-(3-aminophenyl)-3-cyclopropyl-5-{(2-fluoro-4-iodophenyl)amino}-6,8-dimethylpyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione

trametinib
871700-17-3

trametinib

Conditions
Conditions Yield
With pyridine; acetic anhydride; In chloroform; at 0 - 20 ℃; for 2h;
44.8%

871700-17-3 Upstream products

  • 871700-25-3
    871700-25-3

    N-{3-[3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-ylamino]phenyl}acetamide

  • 871700-37-7
    871700-37-7

    N-(2-fluoro-4-iodophenyl)-N'-methylurea

  • 1258884-52-4
    1258884-52-4

    2-fluoro-4-iodo-N-((methylimino)methylene)aniline

  • 1258884-53-5
    1258884-53-5

    ethyl 2-(2-fluoro-4-iodophenylamino)-4-hydroxy-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxylate

*Product Name
CAS
Purity
Quantity
Company name
*Email
*Other Description
*Code
Fields with* are required
Submit